Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Neuroimage. Clinical
|
April 25, 2021
Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups
Colin Groot, Michel J Grothe, Shubhabrata Mukherjee, et al.
Brain Communications
|
October 15, 2025
Cognitive and physical activities are associated with cognitive resilience in a memory clinic cohort
Diana I Bocancea, Anna C van Loenhoud, Bart Kuijper, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
August 31, 2015
Dendritic and Axonal Architecture of Individual Pyramidal Neurons across Layers of Adult Human Neocortex
Hemanth Mohan, Matthijs B Verhoog, Keerthi K Doreswamy, et al.
Alzheimer'S Research & Therapy
|
August 21, 2024
Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer's disease pathology in the eye clinic
Ilse Bader, Colin Groot, H Stevie Tan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 8, 2021
The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individuals
Gemma Salvadó, Daniel Ferreira, Grégory Operto, et al.
Nature Medicine
|
November 10, 2022
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
Rik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.
JAMA Neurology
|
June 28, 2021
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging
Rik Ossenkoppele, Ruben Smith, Niklas Mattsson-Carlgren, et al.
Neurology
|
July 2, 2021
[<sup>18</sup>F]Flortaucipir PET Across Various <i>MAPT</i> Mutations in Presymptomatic and Symptomatic Carriers
Emma E Wolters, Janne M Papma, Sander C J Verfaillie, et al.
Neurology
|
April 16, 2026
Characterizing Individuals Fulfilling Clinical Criteria for Limbic-Predominant Age-Related TDP-43 Encephalopathy in a Tertiary Memory Clinic
Colin Groot, Ismael L Calandri, Ilse Bader, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 23, 2026
Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action
Nick Corriveau-Lecavalier, Neus Falgàs, Deepti Putcha, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Neuroimage. Clinical
|
April 25, 2021
Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups
Colin Groot, Michel J Grothe, Shubhabrata Mukherjee, et al.
Brain Communications
|
October 15, 2025
Cognitive and physical activities are associated with cognitive resilience in a memory clinic cohort
Diana I Bocancea, Anna C van Loenhoud, Bart Kuijper, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
August 31, 2015
Dendritic and Axonal Architecture of Individual Pyramidal Neurons across Layers of Adult Human Neocortex
Hemanth Mohan, Matthijs B Verhoog, Keerthi K Doreswamy, et al.
Alzheimer'S Research & Therapy
|
August 21, 2024
Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer's disease pathology in the eye clinic
Ilse Bader, Colin Groot, H Stevie Tan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 8, 2021
The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individuals
Gemma Salvadó, Daniel Ferreira, Grégory Operto, et al.
Nature Medicine
|
November 10, 2022
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
Rik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.
JAMA Neurology
|
June 28, 2021
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging
Rik Ossenkoppele, Ruben Smith, Niklas Mattsson-Carlgren, et al.
Neurology
|
July 2, 2021
[<sup>18</sup>F]Flortaucipir PET Across Various <i>MAPT</i> Mutations in Presymptomatic and Symptomatic Carriers
Emma E Wolters, Janne M Papma, Sander C J Verfaillie, et al.
Neurology
|
April 16, 2026
Characterizing Individuals Fulfilling Clinical Criteria for Limbic-Predominant Age-Related TDP-43 Encephalopathy in a Tertiary Memory Clinic
Colin Groot, Ismael L Calandri, Ilse Bader, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 23, 2026
Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action
Nick Corriveau-Lecavalier, Neus Falgàs, Deepti Putcha, et al.
Page
of 7